Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 90 of 95, showing 5 Applications out of 474 total, starting on record 446, ending on 450

# Protocol No Study Title Investigator(s) & Site(s)

446.

ECCT/12/02/02   HIV/HPV-Adolescent Study
    Immunogenicity and Safety of quadrivalent human Papillomavirus Vaccine in HIV-Infected pre-adolescent girls and boys in Kenya.   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
Thika
 
View

447.

ECCT/11/12/04   PENNVAX-G DNA/MVA HIV Vaccine Phase 1 trial
    A Phase I Study of the Safety and Immunogenicity of PENNVAX™-G DNA (Env & Gag) Administered by Intramuscular Biojector® 2000 or by CELLECTRA® Intramuscular Electroporation Device Followed by MVACMDR (HIV-1 CM235 env/ CM240 gag/pol) Boost in Healthy, HIV Uninfected Adults   
Principal Investigator(s)
1. FREDRICK KIPYEGO SAWE
Site(s) in Kenya
KEMRI/Walter Reed Project-Kericho
 
View

448.

ECCT/11/12/02   VAC 46 Trial
    Efficacy Study of ChAd63-MVA ME-TRAP prime-boost Vaccination against Plasmodium falciparum infection.   
Principal Investigator(s)
1. Caroline Amolo Ogwang
Site(s) in Kenya
Junju Dispensary
 
View

449.

ECCT/11/10/05  
    A Phase 3, Open Label, Randomized, Comparative Study to Evaluate Azithromycin Plus Chloroquine and Sulfadoxine Plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Malaria Infection in Pregnant Women in Africa. WRAIR #1775, KEMRI SSC #1983   
Principal Investigator(s)
1. Lucas Otieno Tina
Site(s) in Kenya
1. KEMRI/WRP Kombewa (Kisumu county)
 
View

450.

ECCT/11/10/04   Treatment of Advanced AIDS-KS in Resource-Limited Settings
    A5263/AMC 066 "A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings"   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
View